Upgrade to SI Premium - Free Trial

Fate Therapeutics (FATE) PT Raised to $7 at H.C. Wainwright

May 4, 2026 7:28 AM
(Updated - May 4, 2026 7:33 AM EDT)

H.C. Wainwright analyst Debjit Chattopadhyay raised the price target on Fate ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change